Status Epilepticus: Clinical Trials

5 trials for Status Epilepticus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 not yet recruiting, 1 terminated. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 2, Completed 1, Not yet recruiting 1, Terminated 1

Follow Status Epilepticus: new trials by email Literature Review of Status Epilepticus trials Research Report on Status Epilepticus

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine for the Treatment of Refractory Status Epilepticus
Ketamine, Midazolam - Refractory Status Epilepticus
Phase 4Not yet recruitingThomas Jefferson University502025-11-012025-09-16
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
Perampanel - Refractory Status Epilepticus
Phase 4TerminatedWayne State University12025-10-102025-10-14
The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus
Levetiracetam Injection, Fosphenytoin Injection - Status Epilepticus
Phase 4CompletedDhaka Medical College622023-05-152026-10-07
Comparison of Efficacy of Phenytoin With Levetireacetam for the Management of Children With Status Epilepticus
intravenous levetireacetam - Status Epilepticus
Phase 4Unknownayesha tariq2442019-07-252021-04-02
Levetiracetam Versus Phenytoin in Management of Pediatric Status Epilepticus
Levetiracetam Injection, Phenytoin Injection - Comparison, the Efficacy of Levetireacetam
Phase 4UnknownTanta University602019-01-012019-11-25

Narrower conditions

Epilepsy (1)  ·  Seizures (1)

Broader conditions

Nervous System Diseases (5)  ·  Neurologic Manifestations (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Seizures (4)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)

Interventions

Levetiracetam (2)  ·  Ketamine (1)  ·  Midazolam (1)  ·  Phenytoin (1)  ·  fosphenytoin (1)  ·  perampanel (1)

Sponsors

Dhaka Medical College (1)  ·  Tanta University (1)  ·  Thomas Jefferson University (1)  ·  Wayne State University (1)  ·  ayesha tariq (1)

Countries

United States (2)  ·  Bangladesh (1)  ·  Egypt (1)  ·  Pakistan (1)

Top investigators

Amira Darwish, MD (1)  ·  Dr Md Amirul Islam, MBBS (1)  ·  Dr Reaz Mahmud, MD (1)  ·  Haroon Hamid, MBBS,FCPS (1)  ·  Maysaa Basha, MD (1)  ·  Syed O Shah, MD (1)  ·  Wazim Mohamed, MD (1)